{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/CRL/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-18T15:59:17.982Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":2361,"canonical_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","cik":"0001100682","uei":null,"lei":null,"duns":null,"ticker":"CRL"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":127},"count":100,"timeline":[{"ts":"2026-10-07","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-10-07","url_slug":"/sec/cik-0001100682/4/0001952784-26-000003","accession_number":"0001952784-26-000003","importance":30},{"ts":"2026-10-05","kind":"sec.filing","form_type":"144","title":"144 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-10-05","url_slug":"/sec/cik-0001100682/144/0001969223-26-001063","accession_number":"0001969223-26-001063","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-10-02","url_slug":"/sec/cik-0001100682/4/0001100682-26-000144","accession_number":"0001100682-26-000144","importance":30},{"ts":"2026-09-24","kind":"sec.filing","form_type":"8-K","title":"8-K — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-09-24","url_slug":"/sec/cik-0001100682/8-k/0001100682-26-000142","accession_number":"0001100682-26-000142","importance":35},{"ts":"2026-09-08","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-09-08","url_slug":"/sec/cik-0001100682/schedule-13g-a/0000315066-26-002294","accession_number":"0000315066-26-002294","importance":30},{"ts":"2026-08-27","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-27","url_slug":"/sec/cik-0001100682/4/0001100682-26-000140","accession_number":"0001100682-26-000140","importance":30},{"ts":"2026-08-25","kind":"sec.filing","form_type":"144","title":"144 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-25","url_slug":"/sec/cik-0001100682/144/0001969223-26-000955","accession_number":"0001969223-26-000955","importance":30},{"ts":"2026-08-20","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-20","url_slug":"/sec/cik-0001100682/4/0001100682-26-000134","accession_number":"0001100682-26-000134","importance":30},{"ts":"2026-08-20","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-20","url_slug":"/sec/cik-0001100682/4/0001100682-26-000136","accession_number":"0001100682-26-000136","importance":30},{"ts":"2026-08-20","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-20","url_slug":"/sec/cik-0001100682/4/0001100682-26-000138","accession_number":"0001100682-26-000138","importance":30},{"ts":"2026-08-19","kind":"sec.filing","form_type":"144","title":"144 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-19","url_slug":"/sec/cik-0001100682/144/0001969223-26-000932","accession_number":"0001969223-26-000932","importance":30},{"ts":"2026-08-18","kind":"sec.filing","form_type":"144","title":"144 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-18","url_slug":"/sec/cik-0001100682/144/0001969223-26-000918","accession_number":"0001969223-26-000918","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-13","url_slug":"/sec/cik-0001100682/schedule-13g/0000914208-26-000275","accession_number":"0000914208-26-000275","importance":55},{"ts":"2026-08-13","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-13","url_slug":"/sec/cik-0001100682/4/0001100682-26-000130","accession_number":"0001100682-26-000130","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-13","url_slug":"/sec/cik-0001100682/4/0001100682-26-000132","accession_number":"0001100682-26-000132","importance":30},{"ts":"2026-08-11","kind":"sec.form144","reporter":"Girshick Birgit","title":"Officer, CEO & President","shares":6500,"usd_value":1819350,"security_title":"Common","approx_sale_date":"2026-08-11","accession_number":"0001969223-26-000885","importance":40.36387},{"ts":"2026-08-11","kind":"sec.form144","reporter":"Parisotto Shannon M","title":"Officer","shares":3714,"usd_value":1038657,"security_title":"Common","approx_sale_date":"2026-08-11","accession_number":"0001969223-26-000886","importance":40.207731448},{"ts":"2026-08-11","kind":"sec.insider.s","reporter":"Girshick Birgit","title":"Chief Executive Officer","shares":6500,"price_per_share":279.9,"usd_value":1819350,"security_title":"Common Stock","importance":36.81935},{"ts":"2026-08-11","kind":"sec.insider.s","reporter":"Parisotto Shannon M","title":"CEVP, Disc & Safety Assessment","shares":3714,"price_per_share":279.66,"usd_value":1038657,"security_title":"Common Stock","importance":36.03865724},{"ts":"2026-08-11","kind":"sec.filing","form_type":"144","title":"144 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-11","url_slug":"/sec/cik-0001100682/144/0001969223-26-000885","accession_number":"0001969223-26-000885","importance":30},{"ts":"2026-08-11","kind":"sec.filing","form_type":"144","title":"144 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-11","url_slug":"/sec/cik-0001100682/144/0001969223-26-000886","accession_number":"0001969223-26-000886","importance":30},{"ts":"2026-08-11","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-11","url_slug":"/sec/cik-0001100682/4/0001100682-26-000126","accession_number":"0001100682-26-000126","importance":30},{"ts":"2026-08-11","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-11","url_slug":"/sec/cik-0001100682/4/0001100682-26-000128","accession_number":"0001100682-26-000128","importance":30},{"ts":"2026-08-11","kind":"sec.insider.m","reporter":"Girshick Birgit","title":"Chief Executive Officer","shares":6500,"price_per_share":179.66,"usd_value":1167790,"security_title":"Common Stock","importance":16.16779},{"ts":"2026-08-11","kind":"sec.insider.m","reporter":"Parisotto Shannon M","title":"CEVP, Disc & Safety Assessment","shares":3714,"price_per_share":179.66,"usd_value":667257,"security_title":"Common Stock","importance":15.66725724},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"FOSTER JAMES C","title":null,"shares":28733,"price_per_share":275,"usd_value":7901575,"security_title":"Common Stock","importance":42.901575},{"ts":"2026-08-10","kind":"sec.filing","form_type":"144","title":"144 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-10","url_slug":"/sec/cik-0001100682/144/0001969223-26-000874","accession_number":"0001969223-26-000874","importance":30},{"ts":"2026-08-10","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-10","url_slug":"/sec/cik-0001100682/4/0001100682-26-000122","accession_number":"0001100682-26-000122","importance":30},{"ts":"2026-08-10","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-10","url_slug":"/sec/cik-0001100682/4/0001100682-26-000124","accession_number":"0001100682-26-000124","importance":30},{"ts":"2026-08-10","kind":"sec.insider.m","reporter":"FOSTER JAMES C","title":null,"shares":28733,"price_per_share":179.66,"usd_value":5162171,"security_title":"Common Stock","importance":20.16217078},{"ts":"2026-08-10","kind":"sec.insider.g","reporter":"LaPlume Joseph W","title":"EVP, Corp Strategy & Develop","shares":257,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-08-06","kind":"sec.insider.s","reporter":"Creamer Victoria L","title":"EVP & Chief People Officer","shares":4179,"price_per_share":259.16,"usd_value":1083030,"security_title":"Common Stock","importance":36.08302964},{"ts":"2026-08-06","kind":"sec.insider.s","reporter":"Knell Michael Gunnar","title":"SVP, Finance and CAO","shares":1274,"price_per_share":259.07,"usd_value":330055,"security_title":"Common Stock","importance":35.33005518},{"ts":"2026-08-06","kind":"sec.insider.s","reporter":"Knell Michael Gunnar","title":"SVP, Finance and CAO","shares":1205,"price_per_share":258.53,"usd_value":311529,"security_title":"Common Stock","importance":35.31152865},{"ts":"2026-08-06","kind":"sec.insider.s","reporter":"Knell Michael Gunnar","title":"SVP, Finance and CAO","shares":901,"price_per_share":260.63,"usd_value":234828,"security_title":"Common Stock","importance":35.23482763},{"ts":"2026-08-06","kind":"sec.insider.s","reporter":"Knell Michael Gunnar","title":"SVP, Finance and CAO","shares":810,"price_per_share":261.45,"usd_value":211775,"security_title":"Common Stock","importance":35.2117745},{"ts":"2026-08-06","kind":"sec.insider.s","reporter":"Knell Michael Gunnar","title":"SVP, Finance and CAO","shares":736,"price_per_share":258.53,"usd_value":190278,"security_title":"Common Stock","importance":35.19027808},{"ts":"2026-08-06","kind":"sec.insider.s","reporter":"Knell Michael Gunnar","title":"SVP, Finance and CAO","shares":620,"price_per_share":263.94,"usd_value":163643,"security_title":"Common Stock","importance":35.1636428},{"ts":"2026-08-06","kind":"sec.insider.s","reporter":"Knell Michael Gunnar","title":"SVP, Finance and CAO","shares":482,"price_per_share":265.17,"usd_value":127812,"security_title":"Common Stock","importance":35.12781194},{"ts":"2026-08-06","kind":"sec.insider.s","reporter":"Knell Michael Gunnar","title":"SVP, Finance and CAO","shares":404,"price_per_share":258.53,"usd_value":104446,"security_title":"Common Stock","importance":35.10444612},{"ts":"2026-08-06","kind":"sec.insider.s","reporter":"Knell Michael Gunnar","title":"SVP, Finance and CAO","shares":213,"price_per_share":262.37,"usd_value":55885,"security_title":"Common Stock","importance":35.05588481},{"ts":"2026-08-06","kind":"sec.filing","form_type":"144","title":"144 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-06","url_slug":"/sec/cik-0001100682/144/0001969223-26-000852","accession_number":"0001969223-26-000852","importance":30},{"ts":"2026-08-06","kind":"sec.filing","form_type":"144","title":"144 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-06","url_slug":"/sec/cik-0001100682/144/0001969223-26-000853","accession_number":"0001969223-26-000853","importance":30},{"ts":"2026-08-06","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-06","url_slug":"/sec/cik-0001100682/4/0001100682-26-000120","accession_number":"0001100682-26-000120","importance":30},{"ts":"2026-08-06","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-06","url_slug":"/sec/cik-0001100682/schedule-13g-a/0000315066-26-001960","accession_number":"0000315066-26-001960","importance":30},{"ts":"2026-08-06","kind":"sec.insider.m","reporter":"Creamer Victoria L","title":"EVP & Chief People Officer","shares":4179,"price_per_share":179.66,"usd_value":750799,"security_title":"Common Stock","importance":15.75079914},{"ts":"2026-08-06","kind":"sec.insider.m","reporter":"Knell Michael Gunnar","title":"SVP, Finance and CAO","shares":1205,"price_per_share":194.12,"usd_value":233915,"security_title":"Common Stock","importance":15.2339146},{"ts":"2026-08-06","kind":"sec.insider.m","reporter":"Knell Michael Gunnar","title":"SVP, Finance and CAO","shares":736,"price_per_share":208.44,"usd_value":153412,"security_title":"Common Stock","importance":15.15341184},{"ts":"2026-08-06","kind":"sec.insider.m","reporter":"Knell Michael Gunnar","title":"SVP, Finance and CAO","shares":404,"price_per_share":179.66,"usd_value":72583,"security_title":"Common Stock","importance":15.07258264},{"ts":"2026-08-05","kind":"sec.filing","form_type":"10-Q","title":"10-Q — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-05","url_slug":"/sec/cik-0001100682/10-q/0001100682-26-000118","accession_number":"0001100682-26-000118","importance":45},{"ts":"2026-08-05","kind":"sec.insider.s","reporter":"Parisotto Shannon M","title":"CEVP, Disc & Safety Assessment","shares":5046,"price_per_share":263,"usd_value":1327098,"security_title":"Common Stock","importance":36.327098},{"ts":"2026-08-05","kind":"sec.filing","form_type":"8-K","title":"8-K — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-05","url_slug":"/sec/cik-0001100682/8-k/0001100682-26-000115","accession_number":"0001100682-26-000115","importance":35},{"ts":"2026-08-05","kind":"sec.filing","form_type":"144","title":"144 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-08-05","url_slug":"/sec/cik-0001100682/144/0001969223-26-000848","accession_number":"0001969223-26-000848","importance":30},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"FOSTER JAMES C","title":null,"shares":75000,"price_per_share":225,"usd_value":16875000,"security_title":"Common Stock","importance":51.875},{"ts":"2026-06-29","kind":"sec.form144","reporter":"FOSTER JAMES C","title":"Director","shares":75000,"usd_value":16875000,"security_title":"Common","approx_sale_date":"2026-06-29","accession_number":"0001969223-26-000736","importance":43.375},{"ts":"2026-06-29","kind":"sec.filing","form_type":"144","title":"144 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-06-29","url_slug":"/sec/cik-0001100682/144/0001969223-26-000736","accession_number":"0001969223-26-000736","importance":30},{"ts":"2026-06-08","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-06-08","url_slug":"/sec/cik-0001100682/4/0001100682-26-000105","accession_number":"0001100682-26-000105","importance":30},{"ts":"2026-06-08","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-06-08","url_slug":"/sec/cik-0001100682/4/0001100682-26-000107","accession_number":"0001100682-26-000107","importance":30},{"ts":"2026-06-08","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-06-08","url_slug":"/sec/cik-0001100682/4/0001100682-26-000109","accession_number":"0001100682-26-000109","importance":30},{"ts":"2026-06-05","kind":"sec.insider.g","reporter":"Parisotto Shannon M","title":"CEVP, Disc & Safety Assessment","shares":1529,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-05","kind":"sec.insider.g","reporter":"Parisotto Shannon M","title":"CEVP, Disc & Safety Assessment","shares":1529,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-05","kind":"sec.insider.g","reporter":"FOSTER JAMES C","title":null,"shares":153361,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-05","kind":"sec.insider.g","reporter":"FOSTER JAMES C","title":null,"shares":153361,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-05","kind":"sec.insider.g","reporter":"FOSTER JAMES C","title":null,"shares":20000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-05","kind":"sec.insider.g","reporter":"FOSTER JAMES C","title":null,"shares":20000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-05","kind":"sec.insider.g","reporter":"FOSTER JAMES C","title":null,"shares":10000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-05","kind":"sec.insider.g","reporter":"Girshick Birgit","title":"Chief Executive Officer","shares":3386,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-05","kind":"sec.insider.g","reporter":"Girshick Birgit","title":"Chief Executive Officer","shares":3386,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-05","kind":"sec.insider.g","reporter":"FOSTER JAMES C","title":null,"shares":10000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-03","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-06-03","url_slug":"/sec/cik-0001100682/4/0001100682-26-000103","accession_number":"0001100682-26-000103","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-06-02","url_slug":"/sec/cik-0001100682/4/0001100682-26-000087","accession_number":"0001100682-26-000087","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-06-02","url_slug":"/sec/cik-0001100682/4/0001100682-26-000089","accession_number":"0001100682-26-000089","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-06-02","url_slug":"/sec/cik-0001100682/4/0001100682-26-000091","accession_number":"0001100682-26-000091","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-06-02","url_slug":"/sec/cik-0001100682/4/0001100682-26-000093","accession_number":"0001100682-26-000093","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-06-02","url_slug":"/sec/cik-0001100682/4/0001100682-26-000095","accession_number":"0001100682-26-000095","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-06-02","url_slug":"/sec/cik-0001100682/4/0001100682-26-000097","accession_number":"0001100682-26-000097","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-06-02","url_slug":"/sec/cik-0001100682/4/0001100682-26-000099","accession_number":"0001100682-26-000099","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — 2026-06-02","url_slug":"/sec/cik-0001100682/4/0001100682-26-000101","accession_number":"0001100682-26-000101","importance":30},{"ts":"2026-06-02","kind":"sec.insider.422","reporter":"Barg Steven","title":null,"shares":422,"price_per_share":174.79,"usd_value":73761,"security_title":"Common Stock","importance":15.07376138},{"ts":"2026-06-02","kind":"sec.insider.a","reporter":"Barg Steven","title":null,"shares":422,"price_per_share":174.79,"usd_value":73761,"security_title":"Common Stock","importance":15.07376138},{"ts":"2026-05-31","kind":"sec.insider.f","reporter":"Girshick Birgit","title":"Chief Executive Officer","shares":378,"price_per_share":180.71,"usd_value":68308,"security_title":"Common Stock","importance":15.06830838},{"ts":"2026-05-31","kind":"sec.insider.f","reporter":"LaPlume Joseph W","title":"EVP, Corp Strategy & Develop","shares":235,"price_per_share":180.71,"usd_value":42467,"security_title":"Common Stock","importance":15.04246685},{"ts":"2026-05-31","kind":"sec.insider.f","reporter":"Creamer Victoria L","title":"EVP & Chief People Officer","shares":194,"price_per_share":180.71,"usd_value":35058,"security_title":"Common Stock","importance":15.03505774},{"ts":"2026-05-31","kind":"sec.insider.f","reporter":"Parisotto Shannon M","title":"CEVP, Disc & Safety Assessment","shares":170,"price_per_share":180.71,"usd_value":30721,"security_title":"Common Stock","importance":15.0307207},{"ts":"2026-05-31","kind":"sec.insider.f","reporter":"Mintz Mark","title":"EVP, Chief Information Officer","shares":64,"price_per_share":180.71,"usd_value":11565,"security_title":"Common Stock","importance":15.01156544},{"ts":"2026-05-31","kind":"sec.insider.f","reporter":"Knell Michael Gunnar","title":"SVP, Finance and CAO","shares":48,"price_per_share":180.71,"usd_value":8674,"security_title":"Common Stock","importance":15.00867408},{"ts":"2026-05-30","kind":"sec.insider.f","reporter":"FOSTER JAMES C","title":null,"shares":1596,"price_per_share":180.71,"usd_value":288413,"security_title":"Common Stock","importance":15.28841316},{"ts":"2026-05-30","kind":"sec.insider.f","reporter":"Girshick Birgit","title":"Chief Executive Officer","shares":1204,"price_per_share":180.71,"usd_value":217575,"security_title":"Common Stock","importance":15.21757484},{"ts":"2026-05-30","kind":"sec.insider.f","reporter":"LaPlume Joseph W","title":"EVP, Corp Strategy & Develop","shares":744,"price_per_share":180.71,"usd_value":134448,"security_title":"Common Stock","importance":15.13444824},{"ts":"2026-05-30","kind":"sec.insider.f","reporter":"Creamer Victoria L","title":"EVP & Chief People Officer","shares":616,"price_per_share":180.71,"usd_value":111317,"security_title":"Common Stock","importance":15.11131736},{"ts":"2026-05-30","kind":"sec.insider.f","reporter":"Parisotto Shannon M","title":"CEVP, Disc & Safety Assessment","shares":551,"price_per_share":180.71,"usd_value":99571,"security_title":"Common Stock","importance":15.09957121},{"ts":"2026-05-30","kind":"sec.insider.f","reporter":"Mintz Mark","title":"EVP, Chief Information Officer","shares":305,"price_per_share":180.71,"usd_value":55117,"security_title":"Common Stock","importance":15.05511655},{"ts":"2026-05-30","kind":"sec.insider.f","reporter":"Knell Michael Gunnar","title":"SVP, Finance and CAO","shares":152,"price_per_share":180.71,"usd_value":27468,"security_title":"Common Stock","importance":15.02746792},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"Girshick Birgit","title":"Chief Executive Officer","shares":9961,"price_per_share":180.71,"usd_value":1800052,"security_title":"Common Stock","importance":16.80005231},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"Coleman Glenn","title":"EVP & Chief Financial Officer","shares":6640,"price_per_share":180.71,"usd_value":1199914,"security_title":"Common Stock","importance":16.1999144},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"LaPlume Joseph W","title":"EVP, Corp Strategy & Develop","shares":5257,"price_per_share":180.71,"usd_value":949992,"security_title":"Common Stock","importance":15.94999247},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"Creamer Victoria L","title":"EVP & Chief People Officer","shares":5135,"price_per_share":180.71,"usd_value":927946,"security_title":"Common Stock","importance":15.92794585},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"Parisotto Shannon M","title":"CEVP, Disc & Safety Assessment","shares":4361,"price_per_share":180.71,"usd_value":788076,"security_title":"Common Stock","importance":15.78807631},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"Mintz Mark","title":"EVP, Chief Information Officer","shares":2534,"price_per_share":180.71,"usd_value":457919,"security_title":"Common Stock","importance":15.45791914},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"Knell Michael Gunnar","title":"SVP, Finance and CAO","shares":1837,"price_per_share":180.71,"usd_value":331964,"security_title":"Common Stock","importance":15.33196427}]}